PROC

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.07
Percentage change 2.99	%

Peers: LLY JNJ PFE GSK MRK AMGN BMY ABBV RDY SNY

| Held by: SPEM

Scroll to Statements

Index	-	P/E	4.77	EPS (ttm)	0.51	Insider Own	14.07%	Shs Outstand	112.59M	Perf Week	59.60%
Market Cap	280.04M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	96.95M	Perf Month	183.53%
Income	52.20M	PEG	-	EPS next Q	-	Inst Own	0.10%	Short Float	0.22%	Perf Quarter	30.98%
Sales	414.10M	P/S	0.68	EPS this Y	-	Inst Trans	-29.37%	Short Ratio	2.23	Perf Half Y	-15.40%
Book/sh	0.35	P/B	6.89	EPS next Y	-	ROA	10.77%	Short Interest	0.21M	Perf Year	-5.35%
Cash/sh	0.15	P/C	15.95	EPS next 5Y	-	ROE	350.21%	52W Range	0.50 - 4.95	Perf YTD	-40.79%
Dividend Est.	-	P/FCF	13.71	EPS past 5Y	-	ROI	20.07%	52W High	-51.31%	Beta	0.07
Dividend TTM	-	Quick Ratio	0.99	Sales past 5Y	-	Gross Margin	55.04%	52W Low	382.00%	ATR (14)	0.28
Dividend Ex-Date	-	Current Ratio	1.47	EPS Y/Y TTM	164.95%	Oper. Margin	8.15%	RSI (14)	63.76	Volatility	20.15% 27.47%
Employees	-	Debt/Eq	7.36	Sales Y/Y TTM	-4.80%	Profit Margin	12.61%	Recom	3.00	Target Price	4.50
Option/Short	No / Yes	LT Debt/Eq	5.60	EPS Q/Q	-63.68%	Payout	-	Rel Volume	0.18	Prev Close	2.34
Sales Surprise	6.88%	EPS Surprise	0.00%	Sales Q/Q	7.25%	Earnings	-	Avg Volume	93.31K	Price	2.41
SMA20	60.88%	SMA50	43.29%	SMA200	2.20%	Trades		Volume	16,407	Change	2.99%

Dec-03-24 05:18PM	Procaps Group Announces Financing, Shareholders Agreement and Board Updates (GlobeNewswire) -12.62% +11.27%
Nov-15-24 06:15PM	Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing (GlobeNewswire) -13.21% -11.59%
Oct-10-24 05:26PM	Procaps Issues Shareholder Letter Update (GlobeNewswire) -5.81% -6.59%
Sep-18-24 08:10AM	Procaps Issues Shareholder Letter Update (GlobeNewswire)
Sep-03-24 09:10AM	Procaps Issues Shareholder Letter (GlobeNewswire)
02:18PM	Loading…
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-28-24 08:31AM	Procaps Group Announces New Chairman (Business Wire)
May-20-24 04:05PM	Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F (Business Wire) +9.40%
May-14-24 04:10PM	Procaps Group Delays Filing of Annual Report on Form 20-F (Business Wire) -5.82%
May-01-24 04:10PM	Procaps Group Delays Filing of Annual Report on Form 20-F (Business Wire) +5.92% +7.03%
Mar-04-24 08:00AM	Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives (Business Wire) +8.05%
Feb-05-24 08:50AM	Procaps Issues Shareholder Letter from New CEO (Business Wire)
Jan-16-24 08:50AM	Procaps Group Notice to Shareholders (Business Wire)
Dec-26-23 05:40PM	Procaps Group Reports Third Quarter 2023 Results (Business Wire) +13.71%
Dec-21-23 06:45PM	Statement from the Board of Directors of Procaps Group (Business Wire) +7.74%
07:54PM	Loading…
Nov-29-23 07:54PM	Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America (PR Newswire)
Nov-22-23 08:30AM	Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024 (Business Wire) +19.39%
Nov-14-23 05:25PM	Procaps Group Update on Third Quarter Results (Business Wire) +10.63% -11.03%
Nov-10-23 11:37AM	Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023 (Business Wire) -6.28%
Oct-30-23 08:30AM	Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia (Business Wire)
Oct-23-23 05:01PM	Procaps Appoints Sandra Snchez y Oldenhage to Board of Directors (Business Wire) +12.84%
Oct-16-23 08:31AM	Procaps Group to Participate at CPHI Barcelona 2023 (Business Wire) -9.22%
Oct-02-23 08:00AM	Procaps Group to Host Webinar on Colombian Pharma Market (Business Wire)
Sep-15-23 08:20AM	Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October (Business Wire)
Sep-07-23 08:30AM	Procaps Group Announces the Expansion of its Oncology Portfolio (Business Wire)
Sep-05-23 08:25AM	Procaps Group Reports Second Quarter 2023 Results (Business Wire)
Aug-31-23 06:35PM	Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday (Business Wire)
Aug-16-23 08:31AM	Procaps Group Publishes White Paper on Innovative Gummy Technology (Business Wire)
Jun-05-23 07:45PM	Procaps Group Reports First Quarter 2023 Results (GlobeNewswire)
May-12-23 05:30PM	Procaps Group Reports Fourth Quarter and Full Year 2022 Results (Business Wire)
08:17AM	Loading…
May-01-23 08:17AM	Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing (GlobeNewswire)
Feb-13-23 04:36PM	Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance (GlobeNewswire) +7.07%
Jan-19-23 04:32PM	Procaps Announces Key Changes to the Board of Directors (GlobeNewswire) -7.98%
Jan-03-23 04:13PM	Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar (GlobeNewswire) -10.86%
Dec-29-22 08:00AM	Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-22 04:02PM	Update on Proposed Acquisition of Grupo Somar (GlobeNewswire) -9.86%
Nov-14-22 05:32PM	Procaps Group Reports Third Quarter and Nine Months 2022 Results (GlobeNewswire)
Nov-08-22 03:36PM	Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022 (GlobeNewswire)
Oct-11-22 08:00AM	Procaps Announces ESG Commitments and Initiatives with Inaugural Report (GlobeNewswire)
Oct-05-22 10:15AM	Procaps Group to Participate in the BTG Pactual LatAm CEO Conference (GlobeNewswire)
Aug-30-22 06:40AM	Procaps Group Reports Second Quarter and First Half 2022 Results (GlobeNewswire)
Aug-15-22 06:25AM	Calculating The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC) (Simply Wall St.)
Jun-26-22 08:33AM	Analysts Are Optimistic We'll See A Profit From Procaps Group S.A. (NASDAQ:PROC) (Simply Wall St.)
Jun-02-22 08:14AM	Procaps Group Reports Preliminary First Quarter 2022 Results (GlobeNewswire) +6.22%
May-22-22 10:31AM	Is Procaps Group S.A.'s (NASDAQ:PROC) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
May-17-22 04:44PM	Procaps Group to Acquire Grupo Somar (including Química y Farmacia, Gelcaps and related entities) from Advent International, gaining an important presence in Mexico, the Region's Second Largest Market (GlobeNewswire) +14.32%
Apr-29-22 09:12PM	Procaps Group Reports Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire)
Apr-22-22 08:20AM	Procaps Group (NASDAQ:PROC) shareholders have endured a 18% loss from investing in the stock a year ago (Simply Wall St.)
Mar-08-22 04:38AM	A Look At The Fair Value Of Procaps Group, S.A. (NASDAQ:PROC) (Simply Wall St.)
Feb-08-22 01:38PM	Sagil Capital LLP Buys iShares MSCI Emerging Markets ETF, Ternium SA, Petroleo Brasileiro SA ... (GuruFocus.com)
Feb-02-22 08:31AM	Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida (Business Wire)
Jan-28-22 09:26AM	Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director (Business Wire)
Jan-12-22 08:31AM	Procaps Group Acquires 1st U.S.-Based Softgel Production Facility and Pharmaceutical R&D Center to Expand Global Growth of its iCDMO Business Unit (Business Wire)
Nov-29-21 07:58AM	Could The Procaps Group, S.A. (NASDAQ:PROC) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Nov-19-21 08:41AM	Procaps Group Reports Record Third Quarter 2021 Financial Results (Business Wire)

Procaps Group SA is an international healthcare and pharmaceutical company. The firm is engaged in the developing of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It operates through the following segments: NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. The NextGel segment is involved in the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in USA, Brazil, and Colombia. The Procaps Colombia segment is focused on the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Colombia. The CAN segment deals with the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Northern Central America: Salvador, Guatemala, Nicaragua, and Honduras. The CASAND segment offers pharmaceutical products in Southern Central America that include Panama and Costa Rica, and the North Andes District that include Ecuador, Peru, and Bolivia. The Diabetrics segment consists of the diabetes solutions and chronic disease management tool. The company was founded by Ruben Minski in 1977 and is headquartered in Luxembourg.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Procaps Group S.A

Upgrade your FINVIZ experience